Axcelis Technologies, Inc. — Q3 2023 Form 10-Q
Business and period: Axcelis makes ion implantation equipment for semiconductor manufacturing and provides aftermarket parts, upgrades and service. This unaudited report covers the quarter and nine months ended September 30, 2023; comparisons are with the same 2022 periods. Amounts below are in millions unless stated otherwise.
Financial performance
| Metric | Q3 2023 | Q3 2022 | First 9 months 2023 | First 9 months 2022 |
|---|---|---|---|---|
| Revenue | $292.3 (+27.6%) | $229.2 | $820.3 (+25.4%) | $653.9 |
| Gross profit / margin | $129.7 / 44.3% | $103.3 / 45.1% | $353.4 / 43.0% | $292.3 / 44.7% |
| Operating income | $71.7 (+34.7%) | $53.2 | $186.7 (+19.5%) | $156.3 |
| Net income | $65.9 (+63.7%) | $40.3 | $175.2 (+39.0%) | $126.1 |
| Diluted EPS | $1.99 | $1.21 | $5.28 | $3.75 |
| Operating cash flow | Not separately provided | Not separately provided | $91.3 | $93.2 |
Q3 system revenue was $231.5 million versus $171.1 million; aftermarket revenue was $60.9 million versus $58.1 million. For the first nine months, systems revenue was $641.8 million versus $488.2 million and aftermarket was $178.5 million versus $165.7 million. Asia Pacific accounted for $582.2 million of nine-month revenue, North America $134.6 million and Europe $103.4 million.
Gross margin declined year over year, primarily due to a less favorable mix of system revenue. Q3 product gross margin was 45.4% versus 46.3%; nine-month product gross margin was 44.1% versus 45.8%. Operating expenses rose 15.7% in Q3 and 22.5% over nine months, including higher personnel, R&D and project costs. Improved interest income and lower foreign-exchange losses helped lift other income versus 2022.
Liquidity, capital and balance sheet
- At September 30, 2023, cash and equivalents were $142.3 million and short-term investments $318.7 million; restricted cash was $6.7 million. Cash plus short-term investments totaled $461.0 million.
- Operating cash flow was $91.3 million for the first nine months, compared with $93.2 million in 2022. Working-capital outflows included $79.5 million for inventory and $26.7 million for receivables.
- Capital expenditures and capitalized software were $10.5 million. Investing cash outflow was $74.2 million, reflecting purchases and maturities of short-term investments.
- Financing cash outflow was $53.2 million, including $37.5 million of share repurchases and $15.8 million of tax withholding on vested restricted stock units. Axcelis repurchased 0.3 million shares in the nine-month period at an average $137.54 per share.
- The company reported $45.5 million of finance lease obligations and $30.9 million of operating lease obligations. It terminated its $40 million revolving credit facility in April 2023; the filing reports no outstanding borrowings under that facility. A $5.9 million headquarters lease letter of credit was replaced by cash collateral.
- Current assets were $1,015.0 million and current liabilities $261.2 million. Total liabilities were $400.7 million; total stockholders’ equity was $801.0 million. Deferred revenue was $202.0 million, up from $154.8 million at year-end 2022.
Outlook, commentary and risks
- Management described demand for capital equipment as strong in the first nine months despite a downturn in memory markets affecting other equipment makers. It said supply-chain performance had improved but had not fully recovered.
- Management noted that 94% of shipments in the first nine months went to mature foundry/logic customers. The ten largest customers represented 55.1% of nine-month revenue; one customer represented 10.7%. Three customers each represented more than 10% of accounts receivable at quarter-end.
- No specific revenue, earnings or margin guidance is provided in the supplied filing text. Management said current cash and cash equivalents should meet anticipated short- and long-term cash requirements, while also citing business ramp needs, share repurchases and potential organic or inorganic growth opportunities.
- Key exposures include semiconductor capital-spending cycles, customer and geographic concentration, fab utilization affecting aftermarket demand, supply-chain constraints, foreign-exchange movements and inventory demand estimates. Inventory rose to $312.2 million from $242.4 million at year-end; the company recorded $3.9 million of excess and obsolete inventory provision during the nine months.
- Axcelis reported no litigation it believes would materially adversely affect operations and no material changes to the risk factors in its 2022 Form 10-K. It recorded a $10.6 million U.S. valuation allowance against certain tax credits and state net operating losses. The filing identifies no significant off-balance-sheet hedging arrangements.
Most important facts for investors to verify
- Whether system demand and order conversion remain resilient, particularly given the semiconductor memory downturn and customers’ capital-spending cycles.
- Whether gross margins stabilize after the reported system-mix-related declines, and whether operating expense growth produces continued earnings growth.
- Whether cash generation improves as inventory and other working-capital requirements evolve; compare operating cash flow with net income.
- Customer concentration, receivable collectability and the implications of deferred revenue growth for future shipments and revenue recognition.
- Execution and cash requirements for the operating ramp, new manufacturing/logistics capacity and the expanded share repurchase authorization.